0000934549 true Correct the certifications 2022 Q3 --12-31 0000934549 2022-01-01 2022-09-30 0000934549 2022-11-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q/A

 

Amendment No. 1

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ______________

 

Commission file number: 1-37721

 

Acacia Research Corporation

(Name of registrant as specified in its charter)

 

Delaware 95-4405754
(State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.)

 

767 Third Avenue,  
6th Floor  
New York,  
NY 10017
(Address of principal executive offices) (Zip Code)

 

(332) 236-8500

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol Name of Each Exchange on Which Registered
Common Stock ACTG The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller reporting company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares outstanding of the registrant’s common stock, par value $0.001 per share, as of November 7, 2022, was 43,540,276.

 

   

 

 

EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 (this “Amendment”) to the Acacia Research Corporation Quarterly Report on Form 10-Q (the “Original Form 10-Q”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on November 10, 2022, is to correct certain clerical errors in the certifications of our Principal Executive Officer and Principal Financial Officer in Exhibits 31.1, 31.2, 32.1 and 32.2, previously included with the Original Form 10-Q.

 

This Amendment contains only the cover page, the Explanatory Note, Item 6. Exhibits, the Signature Page and the corrected officer certifications identified above. Except as described above, no other changes have been made to the Original Form 10-Q.

 

This Amendment does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the Original Form 10-Q. Accordingly, this Amendment should be read in conjunction with the Original Form 10-Q and our other filings with the SEC.

 

ITEM 6. EXHIBITS

 

EXHIBIT

NUMBER

  EXHIBIT
31.1#   Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2#   Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1†   Certification of Principal Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2†   Certification of Principal Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
104#   Cover Page Interactive Data File (formatted in iXBRL)

_________________________

 

#Filed herewith.

 

The certifications attached as Exhibits 32.1 and 32.2 that accompany this Amendment pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the Registrant’s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing.

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ACACIA RESEARCH CORPORATION
   
Date: November 14, 2022 /s/ Martin D. McNulty Jr.
  By: Martin D. McNulty Jr.
 

Interim Chief Executive Officer

(Principal Executive Officer and Duly Authorized Signatory)

 

   
Date: November 14, 2022 /s/ Richard Rosenstein
  By: Richard Rosenstein
 

Chief Financial Officer

(Principal Financial Officer)

 

 

 

 

 

 3